InsidersTradesSigma
Track the DIANTHUS THERAPEUTICS INC stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). The latest transaction was disclosed on 17 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: ADAM M VENESS. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
DIANTHUS THERAPEUTICS INC is a company focused on developing innovative therapies for cancer treatment. It specializes in research and the development of targeted therapeutic solutions.